Citation: B. Sundmanengberg et al., EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 255-260
Citation: B. Sundmanengberg et al., TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 17-23
Citation: Ag. Smolowicz et al., RECRUITMENT OF CD34(-CELLS DURING A SINGLE APHERESIS AFTER MOBILIZATION BY CHEMOTHERAPY AND G-CSF()), Bone marrow transplantation, 21, 1998, pp. 650-650
Authors:
MOLLGARD L
TIDEFELT U
SUNDMANENGBERG B
LOFGREN C
LEHMAN S
PAUL C
Citation: L. Mollgard et al., HIGH SINGLE-DOSE OF MITOXANTRONE AND CYTARABINE IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHARMACOKINETIC AND CLINICAL-STUDY, Therapeutic drug monitoring, 20(6), 1998, pp. 640-645
Authors:
FERGEDAL M
ASTROM M
TIDEFELT U
KARLSSON MG
Citation: M. Fergedal et al., DIFFERENCES IN CD14 AND ALPHA-NAPHTHYL ACETATE ESTERASE POSITIVITY AND RELATION TO PROGNOSIS IN AML, Leukemia research, 22(1), 1998, pp. 25-30
Citation: Ag. Smolowicz et al., LARGE-VOLUME APHERESIS FOR THE HARVEST OF PERIPHERAL-BLOOD PROGENITORCELLS FOR AUTOLOGOUS TRANSPLANTATION, Transfusion, 37(2), 1997, pp. 188-192
Authors:
MOLLGARD L
PRENKERT M
SMOLOWICZ A
LEHMAN S
TIDEFELT U
Citation: L. Mollgard et al., FLOW-CYTOMETRY IN-VITRO CHEMOSENSITIVITY TESTING WITH PROPIDIUMIODID AND PHYCOERYTHRIN LABELED ANTIBODIES IN ACUTE NON LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 3648-3648
Authors:
PAUL C
TIDEFELT U
GRUBER A
LILIEMARK E
SUNDMANENGBERG B
JULIUSSON G
STENKE L
ELMHORNROSENBORG A
MOLLGARD L
LEHMANN S
COVELLI A
MALKHANDI J
GUSTAVSSON B
LILIEMARK J
Citation: C. Paul et al., THE P-GLYCOPROTEIN INHIBITOR (PGP) PSC-833 INCREASES THE INTRACELLULAR CONCENTRATIONS OF DAUNORUBICIN (DNR) IN-VIVO IN PATIENTS WITH PGP POSITIVE AML, Blood, 90(10), 1997, pp. 805-805
Authors:
JOHNSEN HE
BJORKSTRAND B
CARLSON K
GRUBER A
BLYSTAD A
FAST A
BOESEN AM
BJORKHOLM M
SALLERFORS B
RUUTU T
CARNESKOG J
MALM A
GEISLER C
LEHTINEN M
SCHRODER H
BRINCH L
REMES K
TIDEFELT U
HEILMANN C
HORNSTEN P
THORLING K
DAUGAARD G
Citation: He. Johnsen et al., OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT, Leukemia & lymphoma, 24(1-2), 1996, pp. 81-91
Citation: B. Sundmanengberg et al., EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS ON LEUKEMIC-CELLS IN-VITRO AND IN-VIVO, European journal of haematology, 56(1-2), 1996, pp. 1-6
Citation: U. Tidefelt et al., COMPARISON OF IDARUBICIN AND DAUNORUBICIN AND THEIR MAIN METABOLITES REGARDING INTRACELLULAR UPTAKE AND EFFECT ON SENSITIVE AND MULTIDRUG-RESISTANT HL-60 CELLS, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 476-480
Authors:
MOLLGARD L
PRENKERT M
SMOLOWICZ A
TIDEFELT U
Citation: L. Mollgard et al., FLOW-CYTOMETRY IN-VITRO CHEMOSENSITIVITY TESTING WITH PROPIDIUMIODIDEAND PHYCOERYTHRIN LABELED ANTIBODIES IN ACUTE NON LYMPHOCYTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 3323-3323
Authors:
LILIEMARK J
BJORKHOLM M
UDEN AM
HAST R
PAUL C
SIMONSSON B
TIDEFELT U
JULIUSSON G
HEDENUS M
EVENSEN S
TANGEN JM
SJO M
NESTHUS I
HESTDAL K
Citation: J. Liliemark et al., A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/, Blood, 88(10), 1996, pp. 854-854
Authors:
BJORKHOLM M
LILIEMARK J
GAHRTON G
GRIMFORS G
GRUBER A
HAST R
JULIUSSON G
JARNMARK M
KILLANDER A
KIMBY E
LERNER R
LJUNGMAN P
LONNQVIST B
PALMBLAD J
PAUL C
PETTERSON C
SIMONSSON B
STALFELT AM
STENKE L
SUNDSTROM C
TIDEFELT U
UDEN AM
OBERG G
OST A
Citation: M. Bjorkholm et al., MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON, European journal of haematology, 55(1), 1995, pp. 19-23
Authors:
GRUBER A
LILIEMARK E
TIDEFELT U
PAUL C
BJORKHOLM M
PETERSON C
LILIEMARK J
Citation: A. Gruber et al., PHARMACOKINETICS OF MITOXANTRONE, ETOPOSIDE AND CYTOSINE-ARABINOSIDE IN LEUKEMIC-CELLS DURING TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP TO TREATMENT OUTCOME AND BONE-MARROW TOXICITY, Leukemia research, 19(10), 1995, pp. 757-761
Citation: U. Tidefelt et al., COMPARISON OF IDARUBICIN AND DAUNORUBICIN AND THEIR MAIN METABOLITES REGARDING INTRACELLULAR UPTAKE AND EFFECT ON SENSITIVE AND MULTIDRUG-RESISTANT HL-60 CELLS, Blood, 86(10), 1995, pp. 3123-3123
Authors:
JONSSON K
DAHLBERG N
TIDEFELT U
PAUL C
ANDERSSON G
Citation: K. Jonsson et al., CHARACTERIZATION OF AN ANTHRACYCLINE-RESISTANT HUMAN PROMYELOCYTE LEUKEMIA (HL-60) CELL-LINE WITH AN ELEVATED MDR-1 GENE-EXPRESSION, Biochemical pharmacology, 49(6), 1995, pp. 755-762
Authors:
TIDEFELT U
JULIUSSON G
ELMHORNROSENBORG A
PETERSON C
PAUL C
Citation: U. Tidefelt et al., INCREASED INTRACELLULAR CONCENTRATIONS OF DOXORUBICIN IN RESISTANT LYMPHOMA-CELLS IN-VIVO BY CONCOMITANT THERAPY WITH VERAPAMIL AND CYCLOSPORINE-A, European journal of haematology, 52(5), 1994, pp. 276-282
Citation: U. Tidefelt et al., COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DAUNORUBICIN AND IDARUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA, Leukemia research, 18(4), 1994, pp. 293-297
Authors:
OSTERBORG A
BJORKHOLM M
BJOREMAN M
BRENNING G
CARLSON K
CELSING F
GAHRTON G
GRIMFORS G
GYLLENHAMMAR H
HAST R
JOHANSSON B
JULIUSSON G
JARNMARK M
KIMBY E
LERNER R
LINDEMALM C
LINDER O
OHRLING M
PAUL C
SIMONSSON B
SKARBERG KF
SMEDMYR B
STRANDER H
SVEDMYR E
TIDEFELT U
UDEN AM
WERNER B
OSBY E
MELLSTEDT H
Citation: A. Osterborg et al., ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY, Blood, 84(10), 1994, pp. 10000657-10000657
Authors:
SUNDMANENGBERG B
TIDEFELT U
GRUBER A
PAUL C
Citation: B. Sundmanengberg et al., INTRACELLULAR CONCENTRATIONS OF MITOXANTRONE IN LEUKEMIC-CELLS INVITRO VS INVIVO, Leukemia research, 17(4), 1993, pp. 347-352